Global Erythropoietin (EPO) Market Insights, Forecast to 2031

Report ID: 1653740 | Published Date: Jan 2025 | No. of Page: 97 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Erythropoietin (EPO) Product Introduction
    1.2 Market by Type
        1.2.1 Global Erythropoietin (EPO) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Epoetin-alfa
        1.2.3 Darbepoetin-alfa
        1.2.4 Epoetin-beta
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Erythropoietin (EPO) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Anemia
        1.3.3 Kidney Disorders
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Erythropoietin (EPO) Sales Estimates and Forecasts 2017-2028
    2.2 Global Erythropoietin (EPO) Revenue Estimates and Forecasts 2017-2028
    2.3 Global Erythropoietin (EPO) Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Erythropoietin (EPO) Sales by Region
        2.4.1 Global Erythropoietin (EPO) Sales by Region (2017-2022)
        2.4.2 Global Sales Erythropoietin (EPO) by Region (2023-2028)
    2.5 Global Erythropoietin (EPO) Revenue by Region
        2.5.1 Global Erythropoietin (EPO) Revenue by Region (2017-2022)
        2.5.2 Global Erythropoietin (EPO) Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Erythropoietin (EPO) Sales by Manufacturers
        3.1.1 Global Top Erythropoietin (EPO) Manufacturers by Sales (2017-2022)
        3.1.2 Global Erythropoietin (EPO) Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Erythropoietin (EPO) in 2021
    3.2 Global Erythropoietin (EPO) Revenue by Manufacturers
        3.2.1 Global Erythropoietin (EPO) Revenue by Manufacturers (2017-2022)
        3.2.2 Global Erythropoietin (EPO) Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Erythropoietin (EPO) Revenue in 2021
    3.3 Global Erythropoietin (EPO) Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Erythropoietin (EPO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Erythropoietin (EPO) Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Erythropoietin (EPO) Sales by Type
        4.1.1 Global Erythropoietin (EPO) Historical Sales by Type (2017-2022)
        4.1.2 Global Erythropoietin (EPO) Forecasted Sales by Type (2023-2028)
        4.1.3 Global Erythropoietin (EPO) Sales Market Share by Type (2017-2028)
    4.2 Global Erythropoietin (EPO) Revenue by Type
        4.2.1 Global Erythropoietin (EPO) Historical Revenue by Type (2017-2022)
        4.2.2 Global Erythropoietin (EPO) Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Erythropoietin (EPO) Revenue Market Share by Type (2017-2028)
    4.3 Global Erythropoietin (EPO) Price by Type
        4.3.1 Global Erythropoietin (EPO) Price by Type (2017-2022)
        4.3.2 Global Erythropoietin (EPO) Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Erythropoietin (EPO) Sales by Application
        5.1.1 Global Erythropoietin (EPO) Historical Sales by Application (2017-2022)
        5.1.2 Global Erythropoietin (EPO) Forecasted Sales by Application (2023-2028)
        5.1.3 Global Erythropoietin (EPO) Sales Market Share by Application (2017-2028)
    5.2 Global Erythropoietin (EPO) Revenue by Application
        5.2.1 Global Erythropoietin (EPO) Historical Revenue by Application (2017-2022)
        5.2.2 Global Erythropoietin (EPO) Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Erythropoietin (EPO) Revenue Market Share by Application (2017-2028)
    5.3 Global Erythropoietin (EPO) Price by Application
        5.3.1 Global Erythropoietin (EPO) Price by Application (2017-2022)
        5.3.2 Global Erythropoietin (EPO) Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Erythropoietin (EPO) Market Size by Type
        6.1.1 North America Erythropoietin (EPO) Sales by Type (2017-2028)
        6.1.2 North America Erythropoietin (EPO) Revenue by Type (2017-2028)
    6.2 North America Erythropoietin (EPO) Market Size by Application
        6.2.1 North America Erythropoietin (EPO) Sales by Application (2017-2028)
        6.2.2 North America Erythropoietin (EPO) Revenue by Application (2017-2028)
    6.3 North America Erythropoietin (EPO) Market Size by Country
        6.3.1 North America Erythropoietin (EPO) Sales by Country (2017-2028)
        6.3.2 North America Erythropoietin (EPO) Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Erythropoietin (EPO) Market Size by Type
        7.1.1 Europe Erythropoietin (EPO) Sales by Type (2017-2028)
        7.1.2 Europe Erythropoietin (EPO) Revenue by Type (2017-2028)
    7.2 Europe Erythropoietin (EPO) Market Size by Application
        7.2.1 Europe Erythropoietin (EPO) Sales by Application (2017-2028)
        7.2.2 Europe Erythropoietin (EPO) Revenue by Application (2017-2028)
    7.3 Europe Erythropoietin (EPO) Market Size by Country
        7.3.1 Europe Erythropoietin (EPO) Sales by Country (2017-2028)
        7.3.2 Europe Erythropoietin (EPO) Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Erythropoietin (EPO) Market Size by Type
        8.1.1 Asia Pacific Erythropoietin (EPO) Sales by Type (2017-2028)
        8.1.2 Asia Pacific Erythropoietin (EPO) Revenue by Type (2017-2028)
    8.2 Asia Pacific Erythropoietin (EPO) Market Size by Application
        8.2.1 Asia Pacific Erythropoietin (EPO) Sales by Application (2017-2028)
        8.2.2 Asia Pacific Erythropoietin (EPO) Revenue by Application (2017-2028)
    8.3 Asia Pacific Erythropoietin (EPO) Market Size by Region
        8.3.1 Asia Pacific Erythropoietin (EPO) Sales by Region (2017-2028)
        8.3.2 Asia Pacific Erythropoietin (EPO) Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Erythropoietin (EPO) Market Size by Type
        9.1.1 Latin America Erythropoietin (EPO) Sales by Type (2017-2028)
        9.1.2 Latin America Erythropoietin (EPO) Revenue by Type (2017-2028)
    9.2 Latin America Erythropoietin (EPO) Market Size by Application
        9.2.1 Latin America Erythropoietin (EPO) Sales by Application (2017-2028)
        9.2.2 Latin America Erythropoietin (EPO) Revenue by Application (2017-2028)
    9.3 Latin America Erythropoietin (EPO) Market Size by Country
        9.3.1 Latin America Erythropoietin (EPO) Sales by Country (2017-2028)
        9.3.2 Latin America Erythropoietin (EPO) Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Erythropoietin (EPO) Market Size by Type
        10.1.1 Middle East and Africa Erythropoietin (EPO) Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Erythropoietin (EPO) Revenue by Type (2017-2028)
    10.2 Middle East and Africa Erythropoietin (EPO) Market Size by Application
        10.2.1 Middle East and Africa Erythropoietin (EPO) Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Erythropoietin (EPO) Revenue by Application (2017-2028)
    10.3 Middle East and Africa Erythropoietin (EPO) Market Size by Country
        10.3.1 Middle East and Africa Erythropoietin (EPO) Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Erythropoietin (EPO) Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Amgen
        11.1.1 Amgen Corporation Information
        11.1.2 Amgen Overview
        11.1.3 Amgen Erythropoietin (EPO) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Amgen Erythropoietin (EPO) Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Amgen Recent Developments
    11.2 Johnson & Johnson
        11.2.1 Johnson & Johnson Corporation Information
        11.2.2 Johnson & Johnson Overview
        11.2.3 Johnson & Johnson Erythropoietin (EPO) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Johnson & Johnson Erythropoietin (EPO) Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Johnson & Johnson Recent Developments
    11.3 Roche
        11.3.1 Roche Corporation Information
        11.3.2 Roche Overview
        11.3.3 Roche Erythropoietin (EPO) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Roche Erythropoietin (EPO) Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Roche Recent Developments
    11.4 Galenica
        11.4.1 Galenica Corporation Information
        11.4.2 Galenica Overview
        11.4.3 Galenica Erythropoietin (EPO) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Galenica Erythropoietin (EPO) Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Galenica Recent Developments
    11.5 Emcure
        11.5.1 Emcure Corporation Information
        11.5.2 Emcure Overview
        11.5.3 Emcure Erythropoietin (EPO) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Emcure Erythropoietin (EPO) Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Emcure Recent Developments
    11.6 Kyowa Hakko Kirin
        11.6.1 Kyowa Hakko Kirin Corporation Information
        11.6.2 Kyowa Hakko Kirin Overview
        11.6.3 Kyowa Hakko Kirin Erythropoietin (EPO) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Kyowa Hakko Kirin Erythropoietin (EPO) Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Kyowa Hakko Kirin Recent Developments
    11.7 3SBio
        11.7.1 3SBio Corporation Information
        11.7.2 3SBio Overview
        11.7.3 3SBio Erythropoietin (EPO) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 3SBio Erythropoietin (EPO) Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 3SBio Recent Developments
    11.8 Biocon
        11.8.1 Biocon Corporation Information
        11.8.2 Biocon Overview
        11.8.3 Biocon Erythropoietin (EPO) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Biocon Erythropoietin (EPO) Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Biocon Recent Developments
    11.9 LG Life Sciences
        11.9.1 LG Life Sciences Corporation Information
        11.9.2 LG Life Sciences Overview
        11.9.3 LG Life Sciences Erythropoietin (EPO) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 LG Life Sciences Erythropoietin (EPO) Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 LG Life Sciences Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Erythropoietin (EPO) Industry Chain Analysis
    12.2 Erythropoietin (EPO) Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Erythropoietin (EPO) Production Mode & Process
    12.4 Erythropoietin (EPO) Sales and Marketing
        12.4.1 Erythropoietin (EPO) Sales Channels
        12.4.2 Erythropoietin (EPO) Distributors
    12.5 Erythropoietin (EPO) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Erythropoietin (EPO) Industry Trends
    13.2 Erythropoietin (EPO) Market Drivers
    13.3 Erythropoietin (EPO) Market Challenges
    13.4 Erythropoietin (EPO) Market Restraints
14 Key Findings in The Global Erythropoietin (EPO) Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Erythropoietin (EPO) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Epoetin-alfa
    Table 3. Major Manufacturers of Darbepoetin-alfa
    Table 4. Major Manufacturers of Epoetin-beta
    Table 5. Major Manufacturers of Others
    Table 6. Global Erythropoietin (EPO) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Erythropoietin (EPO) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Erythropoietin (EPO) Sales by Region (2017-2022) & (K Units)
    Table 9. Global Erythropoietin (EPO) Sales Market Share by Region (2017-2022)
    Table 10. Global Erythropoietin (EPO) Sales by Region (2023-2028) & (K Units)
    Table 11. Global Erythropoietin (EPO) Sales Market Share by Region (2023-2028)
    Table 12. Global Erythropoietin (EPO) Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Erythropoietin (EPO) Revenue Market Share by Region (2017-2022)
    Table 14. Global Erythropoietin (EPO) Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Erythropoietin (EPO) Revenue Market Share by Region (2023-2028)
    Table 16. Global Erythropoietin (EPO) Sales by Manufacturers (2017-2022) & (K Units)
    Table 17. Global Erythropoietin (EPO) Sales Share by Manufacturers (2017-2022)
    Table 18. Global Erythropoietin (EPO) Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Erythropoietin (EPO) Revenue Share by Manufacturers (2017-2022)
    Table 20. Erythropoietin (EPO) Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 21. Global Erythropoietin (EPO) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Erythropoietin (EPO) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erythropoietin (EPO) as of 2021)
    Table 23. Erythropoietin (EPO) Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Erythropoietin (EPO) Product Offered
    Table 25. Date of Manufacturers Enter into Erythropoietin (EPO) Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Erythropoietin (EPO) Sales by Type (2017-2022) & (K Units)
    Table 28. Global Erythropoietin (EPO) Sales by Type (2023-2028) & (K Units)
    Table 29. Global Erythropoietin (EPO) Sales Share by Type (2017-2022)
    Table 30. Global Erythropoietin (EPO) Sales Share by Type (2023-2028)
    Table 31. Global Erythropoietin (EPO) Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Erythropoietin (EPO) Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Erythropoietin (EPO) Revenue Share by Type (2017-2022)
    Table 34. Global Erythropoietin (EPO) Revenue Share by Type (2023-2028)
    Table 35. Erythropoietin (EPO) Price by Type (2017-2022) & (USD/Unit)
    Table 36. Global Erythropoietin (EPO) Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 37. Global Erythropoietin (EPO) Sales by Application (2017-2022) & (K Units)
    Table 38. Global Erythropoietin (EPO) Sales by Application (2023-2028) & (K Units)
    Table 39. Global Erythropoietin (EPO) Sales Share by Application (2017-2022)
    Table 40. Global Erythropoietin (EPO) Sales Share by Application (2023-2028)
    Table 41. Global Erythropoietin (EPO) Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Erythropoietin (EPO) Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Erythropoietin (EPO) Revenue Share by Application (2017-2022)
    Table 44. Global Erythropoietin (EPO) Revenue Share by Application (2023-2028)
    Table 45. Erythropoietin (EPO) Price by Application (2017-2022) & (USD/Unit)
    Table 46. Global Erythropoietin (EPO) Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 47. North America Erythropoietin (EPO) Sales by Type (2017-2022) & (K Units)
    Table 48. North America Erythropoietin (EPO) Sales by Type (2023-2028) & (K Units)
    Table 49. North America Erythropoietin (EPO) Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Erythropoietin (EPO) Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Erythropoietin (EPO) Sales by Application (2017-2022) & (K Units)
    Table 52. North America Erythropoietin (EPO) Sales by Application (2023-2028) & (K Units)
    Table 53. North America Erythropoietin (EPO) Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Erythropoietin (EPO) Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Erythropoietin (EPO) Sales by Country (2017-2022) & (K Units)
    Table 56. North America Erythropoietin (EPO) Sales by Country (2023-2028) & (K Units)
    Table 57. North America Erythropoietin (EPO) Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Erythropoietin (EPO) Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Erythropoietin (EPO) Sales by Type (2017-2022) & (K Units)
    Table 60. Europe Erythropoietin (EPO) Sales by Type (2023-2028) & (K Units)
    Table 61. Europe Erythropoietin (EPO) Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Erythropoietin (EPO) Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Erythropoietin (EPO) Sales by Application (2017-2022) & (K Units)
    Table 64. Europe Erythropoietin (EPO) Sales by Application (2023-2028) & (K Units)
    Table 65. Europe Erythropoietin (EPO) Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Erythropoietin (EPO) Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Erythropoietin (EPO) Sales by Country (2017-2022) & (K Units)
    Table 68. Europe Erythropoietin (EPO) Sales by Country (2023-2028) & (K Units)
    Table 69. Europe Erythropoietin (EPO) Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Erythropoietin (EPO) Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Erythropoietin (EPO) Sales by Type (2017-2022) & (K Units)
    Table 72. Asia Pacific Erythropoietin (EPO) Sales by Type (2023-2028) & (K Units)
    Table 73. Asia Pacific Erythropoietin (EPO) Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Erythropoietin (EPO) Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Erythropoietin (EPO) Sales by Application (2017-2022) & (K Units)
    Table 76. Asia Pacific Erythropoietin (EPO) Sales by Application (2023-2028) & (K Units)
    Table 77. Asia Pacific Erythropoietin (EPO) Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Erythropoietin (EPO) Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Erythropoietin (EPO) Sales by Region (2017-2022) & (K Units)
    Table 80. Asia Pacific Erythropoietin (EPO) Sales by Region (2023-2028) & (K Units)
    Table 81. Asia Pacific Erythropoietin (EPO) Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Erythropoietin (EPO) Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Erythropoietin (EPO) Sales by Type (2017-2022) & (K Units)
    Table 84. Latin America Erythropoietin (EPO) Sales by Type (2023-2028) & (K Units)
    Table 85. Latin America Erythropoietin (EPO) Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Erythropoietin (EPO) Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Erythropoietin (EPO) Sales by Application (2017-2022) & (K Units)
    Table 88. Latin America Erythropoietin (EPO) Sales by Application (2023-2028) & (K Units)
    Table 89. Latin America Erythropoietin (EPO) Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Erythropoietin (EPO) Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Erythropoietin (EPO) Sales by Country (2017-2022) & (K Units)
    Table 92. Latin America Erythropoietin (EPO) Sales by Country (2023-2028) & (K Units)
    Table 93. Latin America Erythropoietin (EPO) Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Erythropoietin (EPO) Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Erythropoietin (EPO) Sales by Type (2017-2022) & (K Units)
    Table 96. Middle East and Africa Erythropoietin (EPO) Sales by Type (2023-2028) & (K Units)
    Table 97. Middle East and Africa Erythropoietin (EPO) Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Erythropoietin (EPO) Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Erythropoietin (EPO) Sales by Application (2017-2022) & (K Units)
    Table 100. Middle East and Africa Erythropoietin (EPO) Sales by Application (2023-2028) & (K Units)
    Table 101. Middle East and Africa Erythropoietin (EPO) Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Erythropoietin (EPO) Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Erythropoietin (EPO) Sales by Country (2017-2022) & (K Units)
    Table 104. Middle East and Africa Erythropoietin (EPO) Sales by Country (2023-2028) & (K Units)
    Table 105. Middle East and Africa Erythropoietin (EPO) Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Erythropoietin (EPO) Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Amgen Corporation Information
    Table 108. Amgen Description and Major Businesses
    Table 109. Amgen Erythropoietin (EPO) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 110. Amgen Erythropoietin (EPO) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Amgen Recent Developments
    Table 112. Johnson & Johnson Corporation Information
    Table 113. Johnson & Johnson Description and Major Businesses
    Table 114. Johnson & Johnson Erythropoietin (EPO) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 115. Johnson & Johnson Erythropoietin (EPO) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Johnson & Johnson Recent Developments
    Table 117. Roche Corporation Information
    Table 118. Roche Description and Major Businesses
    Table 119. Roche Erythropoietin (EPO) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 120. Roche Erythropoietin (EPO) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Roche Recent Developments
    Table 122. Galenica Corporation Information
    Table 123. Galenica Description and Major Businesses
    Table 124. Galenica Erythropoietin (EPO) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 125. Galenica Erythropoietin (EPO) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Galenica Recent Developments
    Table 127. Emcure Corporation Information
    Table 128. Emcure Description and Major Businesses
    Table 129. Emcure Erythropoietin (EPO) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 130. Emcure Erythropoietin (EPO) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Emcure Recent Developments
    Table 132. Kyowa Hakko Kirin Corporation Information
    Table 133. Kyowa Hakko Kirin Description and Major Businesses
    Table 134. Kyowa Hakko Kirin Erythropoietin (EPO) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 135. Kyowa Hakko Kirin Erythropoietin (EPO) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Kyowa Hakko Kirin Recent Developments
    Table 137. 3SBio Corporation Information
    Table 138. 3SBio Description and Major Businesses
    Table 139. 3SBio Erythropoietin (EPO) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 140. 3SBio Erythropoietin (EPO) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. 3SBio Recent Developments
    Table 142. Biocon Corporation Information
    Table 143. Biocon Description and Major Businesses
    Table 144. Biocon Erythropoietin (EPO) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 145. Biocon Erythropoietin (EPO) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Biocon Recent Developments
    Table 147. LG Life Sciences Corporation Information
    Table 148. LG Life Sciences Description and Major Businesses
    Table 149. LG Life Sciences Erythropoietin (EPO) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 150. LG Life Sciences Erythropoietin (EPO) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. LG Life Sciences Recent Developments
    Table 152. Key Raw Materials Lists
    Table 153. Raw Materials Key Suppliers Lists
    Table 154. Erythropoietin (EPO) Distributors List
    Table 155. Erythropoietin (EPO) Customers List
    Table 156. Erythropoietin (EPO) Market Trends
    Table 157. Erythropoietin (EPO) Market Drivers
    Table 158. Erythropoietin (EPO) Market Challenges
    Table 159. Erythropoietin (EPO) Market Restraints
    Table 160. Research Programs/Design for This Report
    Table 161. Key Data Information from Secondary Sources
    Table 162. Key Data Information from Primary Sources
List of Figures
    Figure 1. Erythropoietin (EPO) Product Picture
    Figure 3. Global Erythropoietin (EPO) Market Share by Type in 2021 & 2028
    Figure 3. Epoetin-alfa Product Picture
    Figure 4. Darbepoetin-alfa Product Picture
    Figure 5. Epoetin-beta Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Erythropoietin (EPO) Market Share by Application in 2021 & 2028
    Figure 8. Anemia
    Figure 9. Kidney Disorders
    Figure 10. Other
    Figure 11. Erythropoietin (EPO) Report Years Considered
    Figure 12. Global Erythropoietin (EPO) Sales 2017-2028 (K Units)
    Figure 13. Global Erythropoietin (EPO) Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Erythropoietin (EPO) Revenue 2017-2028 (US$ Million)
    Figure 15. Global Erythropoietin (EPO) Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Erythropoietin (EPO) Sales Market Share by Region (2017-2022)
    Figure 17. Global Erythropoietin (EPO) Sales Market Share by Region (2023-2028)
    Figure 18. North America Erythropoietin (EPO) Sales YoY (2017-2028) & (K Units)
    Figure 19. North America Erythropoietin (EPO) Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Erythropoietin (EPO) Sales YoY (2017-2028) & (K Units)
    Figure 21. Europe Erythropoietin (EPO) Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Erythropoietin (EPO) Sales YoY (2017-2028) & (K Units)
    Figure 23. Asia-Pacific Erythropoietin (EPO) Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Erythropoietin (EPO) Sales YoY (2017-2028) & (K Units)
    Figure 25. Latin America Erythropoietin (EPO) Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Erythropoietin (EPO) Sales YoY (2017-2028) & (K Units)
    Figure 27. Middle East & Africa Erythropoietin (EPO) Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Erythropoietin (EPO) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Erythropoietin (EPO) in the World: Market Share by Erythropoietin (EPO) Revenue in 2021
    Figure 30. Global Erythropoietin (EPO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Erythropoietin (EPO) Sales Market Share by Type (2017-2028)
    Figure 32. Global Erythropoietin (EPO) Revenue Market Share by Type (2017-2028)
    Figure 33. Global Erythropoietin (EPO) Sales Market Share by Application (2017-2028)
    Figure 34. Global Erythropoietin (EPO) Revenue Market Share by Application (2017-2028)
    Figure 35. North America Erythropoietin (EPO) Sales Market Share by Type (2017-2028)
    Figure 36. North America Erythropoietin (EPO) Revenue Market Share by Type (2017-2028)
    Figure 37. North America Erythropoietin (EPO) Sales Market Share by Application (2017-2028)
    Figure 38. North America Erythropoietin (EPO) Revenue Market Share by Application (2017-2028)
    Figure 39. North America Erythropoietin (EPO) Sales Share by Country (2017-2028)
    Figure 40. North America Erythropoietin (EPO) Revenue Share by Country (2017-2028)
    Figure 41. U.S. Erythropoietin (EPO) Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Erythropoietin (EPO) Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Erythropoietin (EPO) Sales Market Share by Type (2017-2028)
    Figure 44. Europe Erythropoietin (EPO) Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Erythropoietin (EPO) Sales Market Share by Application (2017-2028)
    Figure 46. Europe Erythropoietin (EPO) Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Erythropoietin (EPO) Sales Share by Country (2017-2028)
    Figure 48. Europe Erythropoietin (EPO) Revenue Share by Country (2017-2028)
    Figure 49. Germany Erythropoietin (EPO) Revenue (2017-2028) & (US$ Million)
    Figure 50. France Erythropoietin (EPO) Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Erythropoietin (EPO) Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Erythropoietin (EPO) Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Erythropoietin (EPO) Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Erythropoietin (EPO) Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Erythropoietin (EPO) Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Erythropoietin (EPO) Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Erythropoietin (EPO) Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Erythropoietin (EPO) Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Erythropoietin (EPO) Revenue Share by Region (2017-2028)
    Figure 60. China Erythropoietin (EPO) Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Erythropoietin (EPO) Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Erythropoietin (EPO) Revenue (2017-2028) & (US$ Million)
    Figure 63. India Erythropoietin (EPO) Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Erythropoietin (EPO) Revenue (2017-2028) & (US$ Million)
    Figure 65. Taiwan Erythropoietin (EPO) Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Erythropoietin (EPO) Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Erythropoietin (EPO) Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Erythropoietin (EPO) Revenue (2017-2028) & (US$ Million)
    Figure 69. Philippines Erythropoietin (EPO) Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Erythropoietin (EPO) Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Erythropoietin (EPO) Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Erythropoietin (EPO) Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Erythropoietin (EPO) Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Erythropoietin (EPO) Sales Share by Country (2017-2028)
    Figure 75. Latin America Erythropoietin (EPO) Revenue Share by Country (2017-2028)
    Figure 76. Mexico Erythropoietin (EPO) Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Erythropoietin (EPO) Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Erythropoietin (EPO) Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Erythropoietin (EPO) Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Erythropoietin (EPO) Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Erythropoietin (EPO) Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Erythropoietin (EPO) Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Erythropoietin (EPO) Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Erythropoietin (EPO) Revenue Share by Country (2017-2028)
    Figure 85. Turkey Erythropoietin (EPO) Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Erythropoietin (EPO) Revenue (2017-2028) & (US$ Million)
    Figure 87. U.A.E Erythropoietin (EPO) Revenue (2017-2028) & (US$ Million)
    Figure 88. Erythropoietin (EPO) Value Chain
    Figure 89. Erythropoietin (EPO) Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences
Frequently Asked Questions
Erythropoietin (EPO) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Erythropoietin (EPO) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Erythropoietin (EPO) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Glaucoma

Glaucoma market is segmented by players, region (country), by Type and by Application. Players, s ... Read More

Graphic Paper

Graphic Paper market is segmented by Type and by Distribution Channel. Players, stakeholders, and ... Read More